ID   AT1A1_HUMAN             Reviewed;        1023 AA.
AC   P05023; B2RBR6; B7Z2T5; B7Z3U6; F5H3A1; Q16689; Q6LDM4; Q9UCN1;
AC   Q9UJ20; Q9UJ21;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-1987, sequence version 1.
DT   10-MAY-2017, entry version 207.
DE   RecName: Full=Sodium/potassium-transporting ATPase subunit alpha-1;
DE            Short=Na(+)/K(+) ATPase alpha-1 subunit;
DE            EC=3.6.3.9;
DE   AltName: Full=Sodium pump subunit alpha-1;
DE   Flags: Precursor;
GN   Name=ATP1A1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2430951;
RA   Kawakami K., Ohta T., Nojima H., Nagano K.;
RT   "Primary structure of the alpha-subunit of human Na,K-ATPase deduced
RT   from cDNA sequence.";
RL   J. Biochem. 100:389-397(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Retinal pigment epithelium;
RX   PubMed=7536695; DOI=10.1016/0378-1119(94)00812-7;
RA   Ruiz A., Bhat S.P., Bok D.;
RT   "Characterization and quantification of full-length and truncated
RT   Na,K-ATPase alpha 1 and beta 1 RNA transcripts expressed in human
RT   retinal pigment epithelium.";
RL   Gene 155:179-184(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3 AND 4).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, Cervix, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-61.
RX   PubMed=1970326; DOI=10.1016/0888-7543(90)90475-A;
RA   Shull M.M., Pugh D.G., Lingrel J.B.;
RT   "The human Na, K-ATPase alpha 1 gene: characterization of the 5'-
RT   flanking region and identification of a restriction fragment length
RT   polymorphism.";
RL   Genomics 6:451-460(1990).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 85-148.
RC   TISSUE=Placenta;
RA   Zhang J.-S., Yang J.X., Fang M.W., Lu S.D.;
RL   Submitted (MAR-1996) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 168-189 AND 213-244.
RX   PubMed=3035563; DOI=10.1073/pnas.84.12.4039;
RA   Shull M.M., Lingrel J.B.;
RT   "Multiple genes encode the human Na+,K+-ATPase catalytic subunit.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:4039-4043(1987).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 198-943 (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=2891135; DOI=10.1073/pnas.84.22.7901;
RA   Chehab F.F., Kan Y.W., Law M.L., Hartz J., Kao F.T., Blostein R.;
RT   "Human placental Na+,K+-ATPase alpha subunit: cDNA cloning, tissue
RT   expression, DNA polymorphism, and chromosomal localization.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:7901-7905(1987).
RN   [11]
RP   PROTEIN SEQUENCE OF 199-216, AND INTERACTION WITH HLA-DR1.
RX   PubMed=1380674; DOI=10.1038/358764a0;
RA   Chicz R.M., Urban R.G., Lane W.S., Gorga J.C., Stern L.J.,
RA   Vignali D.A.A., Strominger J.L.;
RT   "Predominant naturally processed peptides bound to HLA-DR1 are derived
RT   from MHC-related molecules and are heterogeneous in size.";
RL   Nature 358:764-768(1992).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 253-341 AND 420-444.
RX   PubMed=3036582; DOI=10.1016/0014-5793(87)80677-4;
RA   Sverdlov E.D., Monastyrskaya G.S., Broude N.E., Ushkaryov Y.A.,
RA   Allikmets R.L., Melkov A.M., Smirnov Y.V., Malyshev I.V.,
RA   Dulubova I.E., Petrukhin K.E., Gryshin A.V., Kiyatkin N.I.,
RA   Kostina M.B., Sverdlov V.E., Modyanov N.N., Ovchinnikov Y.A.;
RT   "The family of human Na+,K+-ATPase genes. No less than five genes
RT   and/or pseudogenes related to the alpha-subunit.";
RL   FEBS Lett. 217:275-278(1987).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 471-619.
RA   Ovchinnikov Y.A., Monastyrskaya G.S., Arsenyan S.G., Broude N.E.,
RA   Petrukhin K.E., Grishin A.V., Arzamazova N.M., Severtsova I.V.,
RA   Modyanov N.N.;
RT   "Amino acid sequence of the 17-kilodalton fragment of the cytoplasmic
RT   region of the alpha-subunit of NA+,K+-ATPase.";
RL   Dokl. Biochem. 288:270-272(1986).
RN   [14]
RP   SUBCELLULAR LOCATION.
RX   PubMed=7711835; DOI=10.3109/09687689409160435;
RA   Hundal H.S., Maxwell D.L., Ahmed A., Darakhshan F., Mitsumoto Y.,
RA   Klip A.;
RT   "Subcellular distribution and immunocytochemical localization of Na,K-
RT   ATPase subunit isoforms in human skeletal muscle.";
RL   Mol. Membr. Biol. 11:255-262(1994).
RN   [15]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [16]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-542, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   INTERACTION WITH SLC35G1 AND STIM1.
RX   PubMed=22084111; DOI=10.1073/pnas.1117231108;
RA   Krapivinsky G., Krapivinsky L., Stotz S.C., Manasian Y., Clapham D.E.;
RT   "POST, partner of stromal interaction molecule 1 (STIM1), targets
RT   STIM1 to multiple transporters.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:19234-19239(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: This is the catalytic component of the active enzyme,
CC       which catalyzes the hydrolysis of ATP coupled with the exchange of
CC       sodium and potassium ions across the plasma membrane. This action
CC       creates the electrochemical gradient of sodium and potassium ions,
CC       providing the energy for active transport of various nutrients.
CC   -!- CATALYTIC ACTIVITY: ATP + H(2)O + Na(+)(In) + K(+)(Out) = ADP +
CC       phosphate + Na(+)(Out) + K(+)(In).
CC   -!- SUBUNIT: Interacts with SIK1 (By similarity). Composed of three
CC       subunits: alpha (catalytic), beta and gamma. Binds the HLA class
CC       II histocompatibility antigen, DR1. Interacts with SLC35G1 and
CC       STIM1. {ECO:0000250, ECO:0000269|PubMed:1380674,
CC       ECO:0000269|PubMed:22084111}.
CC   -!- INTERACTION:
CC       P13693:TPT1; NbExp=5; IntAct=EBI-358778, EBI-1783169;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:7711835};
CC       Multi-pass membrane protein {ECO:0000255}. Melanosome
CC       {ECO:0000269|PubMed:17081065}. Note=Identified by mass
CC       spectrometry in melanosome fractions from stage I to stage IV.
CC       {ECO:0000269|PubMed:17081065}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=Long;
CC         IsoId=P05023-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short;
CC         IsoId=P05023-2; Sequence=VSP_000415, VSP_000416;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=3;
CC         IsoId=P05023-3; Sequence=VSP_044242;
CC       Name=4;
CC         IsoId=P05023-4; Sequence=VSP_047309;
CC   -!- PTM: Phosphorylation on Tyr-10 modulates pumping activity.
CC       Phosphorylation of Ser-943 by PKA modulates the response of ATP1A1
CC       to PKC. Dephosphorylation by protein phosphatase 2A (PP2A)
CC       following increases in intracellular sodium, leading to increase
CC       catalytic activity (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the cation transport ATPase (P-type)
CC       (TC 3.A.3) family. Type IIC subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D00099; BAA00061.1; -; mRNA.
DR   EMBL; X04297; CAA27840.1; -; mRNA.
DR   EMBL; U16798; AAC50131.1; -; mRNA.
DR   EMBL; AK295095; BAH11971.1; -; mRNA.
DR   EMBL; AK296362; BAH12332.1; -; mRNA.
DR   EMBL; AK314777; BAG37313.1; -; mRNA.
DR   EMBL; AL136376; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471122; EAW56644.1; -; Genomic_DNA.
DR   EMBL; BC003077; AAH03077.1; -; mRNA.
DR   EMBL; BC001330; AAH01330.1; -; mRNA.
DR   EMBL; BC050359; AAH50359.1; -; mRNA.
DR   EMBL; M30310; AAA51801.1; -; Genomic_DNA.
DR   EMBL; M30309; AAA51801.1; JOINED; Genomic_DNA.
DR   EMBL; L76938; AAA92713.1; -; Genomic_DNA.
DR   EMBL; M16793; AAD56251.1; -; mRNA.
DR   EMBL; M16794; AAD56252.1; -; mRNA.
DR   EMBL; J03007; AAA51803.1; -; mRNA.
DR   EMBL; M27572; AAA35573.1; -; Genomic_DNA.
DR   EMBL; M27579; AAA35574.2; -; Genomic_DNA.
DR   EMBL; X03757; CAA27390.1; -; mRNA.
DR   CCDS; CCDS53351.1; -. [P05023-4]
DR   CCDS; CCDS53352.1; -. [P05023-3]
DR   CCDS; CCDS887.1; -. [P05023-1]
DR   PIR; A24414; A24414.
DR   RefSeq; NP_000692.2; NM_000701.7. [P05023-1]
DR   RefSeq; NP_001153705.1; NM_001160233.1. [P05023-4]
DR   RefSeq; NP_001153706.1; NM_001160234.1. [P05023-3]
DR   RefSeq; XP_016856849.1; XM_017001360.1. [P05023-3]
DR   RefSeq; XP_016856850.1; XM_017001361.1. [P05023-3]
DR   UniGene; Hs.371889; -.
DR   ProteinModelPortal; P05023; -.
DR   SMR; P05023; -.
DR   BioGrid; 106966; 121.
DR   DIP; DIP-38196N; -.
DR   IntAct; P05023; 58.
DR   MINT; MINT-4998863; -.
DR   STRING; 9606.ENSP00000295598; -.
DR   BindingDB; P05023; -.
DR   ChEMBL; CHEMBL1807; -.
DR   DrugBank; DB00511; Acetyldigitoxin.
DR   DrugBank; DB01430; Almitrine.
DR   DrugBank; DB01370; Aluminium.
DR   DrugBank; DB01244; Bepridil.
DR   DrugBank; DB01158; Bretylium.
DR   DrugBank; DB01188; Ciclopirox.
DR   DrugBank; DB01078; Deslanoside.
DR   DrugBank; DB01119; Diazoxide.
DR   DrugBank; DB01396; Digitoxin.
DR   DrugBank; DB00390; Digoxin.
DR   DrugBank; DB00903; Etacrynic acid.
DR   DrugBank; DB00774; Hydroflumethiazide.
DR   DrugBank; DB01378; Magnesium.
DR   DrugBank; DB01092; Ouabain.
DR   DrugBank; DB01345; Potassium.
DR   DrugBank; DB01021; Trichlormethiazide.
DR   TCDB; 3.A.3.1.1; the p-type atpase (p-atpase) superfamily.
DR   iPTMnet; P05023; -.
DR   PhosphoSitePlus; P05023; -.
DR   SwissPalm; P05023; -.
DR   BioMuta; ATP1A1; -.
DR   DMDM; 114374; -.
DR   EPD; P05023; -.
DR   MaxQB; P05023; -.
DR   PaxDb; P05023; -.
DR   PeptideAtlas; P05023; -.
DR   PRIDE; P05023; -.
DR   DNASU; 476; -.
DR   Ensembl; ENST00000295598; ENSP00000295598; ENSG00000163399. [P05023-1]
DR   Ensembl; ENST00000369496; ENSP00000358508; ENSG00000163399. [P05023-3]
DR   Ensembl; ENST00000537345; ENSP00000445306; ENSG00000163399. [P05023-4]
DR   GeneID; 476; -.
DR   KEGG; hsa:476; -.
DR   UCSC; uc001ege.5; human. [P05023-1]
DR   CTD; 476; -.
DR   DisGeNET; 476; -.
DR   GeneCards; ATP1A1; -.
DR   HGNC; HGNC:799; ATP1A1.
DR   HPA; CAB018702; -.
DR   HPA; CAB069993; -.
DR   MIM; 182310; gene.
DR   neXtProt; NX_P05023; -.
DR   OpenTargets; ENSG00000163399; -.
DR   Orphanet; 85142; Aldosterone-producing adenoma.
DR   PharmGKB; PA62; -.
DR   eggNOG; KOG0203; Eukaryota.
DR   eggNOG; COG0474; LUCA.
DR   GeneTree; ENSGT00850000132256; -.
DR   HOGENOM; HOG000265622; -.
DR   HOVERGEN; HBG004298; -.
DR   InParanoid; P05023; -.
DR   KO; K01539; -.
DR   OMA; PVENLCF; -.
DR   OrthoDB; EOG091G01BB; -.
DR   PhylomeDB; P05023; -.
DR   TreeFam; TF312838; -.
DR   Reactome; R-HSA-5578775; Ion homeostasis.
DR   Reactome; R-HSA-936837; Ion transport by P-type ATPases.
DR   ChiTaRS; ATP1A1; human.
DR   GeneWiki; ATPase,_Na%2B/K%2B_transporting,_alpha_1; -.
DR   GenomeRNAi; 476; -.
DR   PRO; PR:P05023; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000163399; -.
DR   CleanEx; HS_ATP1A1; -.
DR   ExpressionAtlas; P05023; baseline and differential.
DR   Genevisible; P05023; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:Ensembl.
DR   GO; GO:0005901; C:caveola; IEA:Ensembl.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:BHF-UCL.
DR   GO; GO:0005768; C:endosome; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:1903561; C:extracellular vesicle; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:BHF-UCL.
DR   GO; GO:0016021; C:integral component of membrane; ISS:UniProtKB.
DR   GO; GO:0014704; C:intercalated disc; IEA:Ensembl.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0043234; C:protein complex; IDA:MGI.
DR   GO; GO:0042383; C:sarcolemma; ISS:BHF-UCL.
DR   GO; GO:0005890; C:sodium:potassium-exchanging ATPase complex; IDA:BHF-UCL.
DR   GO; GO:0030315; C:T-tubule; IEA:Ensembl.
DR   GO; GO:0043531; F:ADP binding; IEA:Ensembl.
DR   GO; GO:0030506; F:ankyrin binding; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; ISS:BHF-UCL.
DR   GO; GO:0051087; F:chaperone binding; IPI:BHF-UCL.
DR   GO; GO:0016791; F:phosphatase activity; IEA:Ensembl.
DR   GO; GO:0043548; F:phosphatidylinositol 3-kinase binding; IEA:Ensembl.
DR   GO; GO:0030955; F:potassium ion binding; ISS:BHF-UCL.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
DR   GO; GO:0031402; F:sodium ion binding; ISS:BHF-UCL.
DR   GO; GO:0005391; F:sodium:potassium-exchanging ATPase activity; IDA:BHF-UCL.
DR   GO; GO:1990239; F:steroid hormone binding; IDA:BHF-UCL.
DR   GO; GO:0086002; P:cardiac muscle cell action potential involved in contraction; TAS:BHF-UCL.
DR   GO; GO:0086064; P:cell communication by electrical coupling involved in cardiac conduction; TAS:BHF-UCL.
DR   GO; GO:0030007; P:cellular potassium ion homeostasis; IDA:BHF-UCL.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl.
DR   GO; GO:0071383; P:cellular response to steroid hormone stimulus; IDA:BHF-UCL.
DR   GO; GO:0006883; P:cellular sodium ion homeostasis; IDA:BHF-UCL.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0060081; P:membrane hyperpolarization; IEA:Ensembl.
DR   GO; GO:0086009; P:membrane repolarization; IDA:BHF-UCL.
DR   GO; GO:0086013; P:membrane repolarization during cardiac muscle cell action potential; IC:BHF-UCL.
DR   GO; GO:0031947; P:negative regulation of glucocorticoid biosynthetic process; IEA:Ensembl.
DR   GO; GO:0045822; P:negative regulation of heart contraction; IEA:Ensembl.
DR   GO; GO:0045823; P:positive regulation of heart contraction; IEA:Ensembl.
DR   GO; GO:0045989; P:positive regulation of striated muscle contraction; IEA:Ensembl.
DR   GO; GO:0010107; P:potassium ion import; IDA:BHF-UCL.
DR   GO; GO:1990573; P:potassium ion import across plasma membrane; ISS:BHF-UCL.
DR   GO; GO:0008217; P:regulation of blood pressure; IEA:Ensembl.
DR   GO; GO:1903779; P:regulation of cardiac conduction; TAS:Reactome.
DR   GO; GO:0086004; P:regulation of cardiac muscle cell contraction; IEA:Ensembl.
DR   GO; GO:0002028; P:regulation of sodium ion transport; ISS:UniProtKB.
DR   GO; GO:0002026; P:regulation of the force of heart contraction; IEA:Ensembl.
DR   GO; GO:0055119; P:relaxation of cardiac muscle; TAS:BHF-UCL.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:1903416; P:response to glycoside; IDA:BHF-UCL.
DR   GO; GO:0036376; P:sodium ion export from cell; IDA:BHF-UCL.
DR   Gene3D; 1.20.1110.10; -; 1.
DR   Gene3D; 2.70.150.10; -; 1.
DR   Gene3D; 3.40.1110.10; -; 2.
DR   InterPro; IPR006068; ATPase_P-typ_cation-transptr_C.
DR   InterPro; IPR004014; ATPase_P-typ_cation-transptr_N.
DR   InterPro; IPR023299; ATPase_P-typ_cyto_domN.
DR   InterPro; IPR018303; ATPase_P-typ_P_site.
DR   InterPro; IPR023298; ATPase_P-typ_TM_dom.
DR   InterPro; IPR008250; ATPase_P-typ_transduc_dom_A.
DR   InterPro; IPR023214; HAD-like_dom.
DR   InterPro; IPR005775; P-type_ATPase_IIC.
DR   InterPro; IPR001757; P_typ_ATPase.
DR   Pfam; PF00689; Cation_ATPase_C; 1.
DR   Pfam; PF00690; Cation_ATPase_N; 1.
DR   Pfam; PF00122; E1-E2_ATPase; 1.
DR   SMART; SM00831; Cation_ATPase_N; 1.
DR   SUPFAM; SSF56784; SSF56784; 3.
DR   SUPFAM; SSF81660; SSF81660; 1.
DR   TIGRFAMs; TIGR01106; ATPase-IIC_X-K; 1.
DR   TIGRFAMs; TIGR01494; ATPase_P-type; 2.
DR   PROSITE; PS00154; ATPASE_E1_E2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ATP-binding; Cell membrane;
KW   Complete proteome; Direct protein sequencing; Hydrolase;
KW   Ion transport; Magnesium; Membrane; Metal-binding; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Potassium; Potassium transport;
KW   Reference proteome; Sodium; Sodium transport;
KW   Sodium/potassium transport; Transmembrane; Transmembrane helix;
KW   Transport.
FT   PROPEP        1      5
FT                                /FTId=PRO_0000002483.
FT   CHAIN         6   1023       Sodium/potassium-transporting ATPase
FT                                subunit alpha-1.
FT                                /FTId=PRO_0000002484.
FT   TOPO_DOM      6     87       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     88    108       Helical. {ECO:0000255}.
FT   TOPO_DOM    109    131       Extracellular. {ECO:0000255}.
FT   TRANSMEM    132    152       Helical. {ECO:0000255}.
FT   TOPO_DOM    153    288       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    289    308       Helical. {ECO:0000255}.
FT   TOPO_DOM    309    320       Extracellular. {ECO:0000255}.
FT   TRANSMEM    321    338       Helical. {ECO:0000255}.
FT   TOPO_DOM    339    772       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    773    792       Helical. {ECO:0000255}.
FT   TOPO_DOM    793    802       Extracellular. {ECO:0000255}.
FT   TRANSMEM    803    823       Helical. {ECO:0000255}.
FT   TOPO_DOM    824    843       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    844    866       Helical. {ECO:0000255}.
FT   TOPO_DOM    867    918       Extracellular. {ECO:0000255}.
FT   TRANSMEM    919    938       Helical. {ECO:0000255}.
FT   TOPO_DOM    939    951       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    952    970       Helical. {ECO:0000255}.
FT   TOPO_DOM    971    985       Extracellular. {ECO:0000255}.
FT   TRANSMEM    986   1006       Helical. {ECO:0000255}.
FT   TOPO_DOM   1007   1023       Cytoplasmic. {ECO:0000255}.
FT   REGION       82     84       Phosphoinositide-3 kinase binding.
FT                                {ECO:0000250}.
FT   ACT_SITE    376    376       4-aspartylphosphate intermediate.
FT                                {ECO:0000250}.
FT   METAL       717    717       Magnesium. {ECO:0000250}.
FT   METAL       721    721       Magnesium. {ECO:0000250}.
FT   BINDING     487    487       ATP. {ECO:0000250}.
FT   MOD_RES       9      9       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8VDN2}.
FT   MOD_RES      10     10       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P06685}.
FT   MOD_RES      16     16       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      21     21       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8VDN2}.
FT   MOD_RES      40     40       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P06685}.
FT   MOD_RES      47     47       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P06685}.
FT   MOD_RES     228    228       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8VDN2}.
FT   MOD_RES     260    260       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q8VDN2}.
FT   MOD_RES     452    452       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P06685}.
FT   MOD_RES     484    484       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P06685}.
FT   MOD_RES     542    542       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     661    661       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8VDN2}.
FT   MOD_RES     668    668       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8VDN2}.
FT   MOD_RES     675    675       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8VDN2}.
FT   MOD_RES     943    943       Phosphoserine; by PKA. {ECO:0000250}.
FT   VAR_SEQ       1     31       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044242.
FT   VAR_SEQ       2      4       GKG -> AFK (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_047309.
FT   VAR_SEQ     638    681       NETVEDIAARLNIPVSQVNPRDAKACVVHGSDLKDMTSEQL
FT                                DDI -> SGPMSRGKSWSSPATQPSSSVSWWCSGPTWSSVR
FT                                PGGIRSSSRG (in isoform 2).
FT                                {ECO:0000303|PubMed:7536695}.
FT                                /FTId=VSP_000415.
FT   VAR_SEQ     682   1023       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:7536695}.
FT                                /FTId=VSP_000416.
FT   VARIANT      47     47       S -> I (in dbSNP:rs12564026).
FT                                /FTId=VAR_048374.
FT   CONFLICT    248    248       N -> S (in Ref. 3; BAG37313).
FT                                {ECO:0000305}.
FT   CONFLICT    323    323       F -> L (in Ref. 3; BAH11971).
FT                                {ECO:0000305}.
FT   CONFLICT    475    475       A -> T (in Ref. 13; CAA27390).
FT                                {ECO:0000305}.
FT   CONFLICT    499    499       S -> A (in Ref. 13; CAA27390).
FT                                {ECO:0000305}.
FT   CONFLICT    502    502       Q -> R (in Ref. 13; CAA27390).
FT                                {ECO:0000305}.
FT   CONFLICT    523    523       L -> I (in Ref. 13; CAA27390).
FT                                {ECO:0000305}.
FT   CONFLICT    892    892       D -> G (in Ref. 3; BAH11971).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1023 AA;  112896 MW;  F3C6FDE04FB3F667 CRC64;
     MGKGVGRDKY EPAAVSEQGD KKGKKGKKDR DMDELKKEVS MDDHKLSLDE LHRKYGTDLS
     RGLTSARAAE ILARDGPNAL TPPPTTPEWI KFCRQLFGGF SMLLWIGAIL CFLAYSIQAA
     TEEEPQNDNL YLGVVLSAVV IITGCFSYYQ EAKSSKIMES FKNMVPQQAL VIRNGEKMSI
     NAEEVVVGDL VEVKGGDRIP ADLRIISANG CKVDNSSLTG ESEPQTRSPD FTNENPLETR
     NIAFFSTNCV EGTARGIVVY TGDRTVMGRI ATLASGLEGG QTPIAAEIEH FIHIITGVAV
     FLGVSFFILS LILEYTWLEA VIFLIGIIVA NVPEGLLATV TVCLTLTAKR MARKNCLVKN
     LEAVETLGST STICSDKTGT LTQNRMTVAH MWFDNQIHEA DTTENQSGVS FDKTSATWLA
     LSRIAGLCNR AVFQANQENL PILKRAVAGD ASESALLKCI ELCCGSVKEM RERYAKIVEI
     PFNSTNKYQL SIHKNPNTSE PQHLLVMKGA PERILDRCSS ILLHGKEQPL DEELKDAFQN
     AYLELGGLGE RVLGFCHLFL PDEQFPEGFQ FDTDDVNFPI DNLCFVGLIS MIDPPRAAVP
     DAVGKCRSAG IKVIMVTGDH PITAKAIAKG VGIISEGNET VEDIAARLNI PVSQVNPRDA
     KACVVHGSDL KDMTSEQLDD ILKYHTEIVF ARTSPQQKLI IVEGCQRQGA IVAVTGDGVN
     DSPALKKADI GVAMGIAGSD VSKQAADMIL LDDNFASIVT GVEEGRLIFD NLKKSIAYTL
     TSNIPEITPF LIFIIANIPL PLGTVTILCI DLGTDMVPAI SLAYEQAESD IMKRQPRNPK
     TDKLVNERLI SMAYGQIGMI QALGGFFTYF VILAENGFLP IHLLGLRVDW DDRWINDVED
     SYGQQWTYEQ RKIVEFTCHT AFFVSIVVVQ WADLVICKTR RNSVFQQGMK NKILIFGLFE
     ETALAAFLSY CPGMGVALRM YPLKPTWWFC AFPYSLLIFV YDEVRKLIIR RRPGGWVEKE
     TYY
//
